The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. This post contains presentations given by the OHE team. The 2016 HTAi Annual…
The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. This post contains presentations given by the OHE team.
The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. Several members of the OHE team attended and contributed to the conference. This post contains presentations by the OHE team.
Dimensions of Value, Assessment, and Decision Making by Adrian Towse
In a Breakfast Symposium, Adrian Towse presented on “Dimensions of Value, Assessment, and Decision Making” setting out a framework for (i) Identifying the elements of value (ii) the use of categories or discrete scales to rate / value these elements (iii) how to weight and aggregate these elements to arrive at a “decision on value” and (iv) translation to price and affordability using cost-effectiveness or therapeutic added value approaches.
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potential for PBRSAs by Adrian Towse
Adrian Towse presented in a Panel entitled “How can HTA’s in Asia respond to Increased Clinical Uncertainty?” on the potential for using risk Sharing Agreements, looking at how to implement risk sharing and managed entry agreements, examining case studies and international best practice, identifying barriers and opportunities.
Operationalising Value-based Pricing: Do we know what we value and what we are giving up to get it? by Adrian Towse
In a Panel Session Adrian Towse presented on “Operationalising Value-based Pricing: Do we know what we Value and What we are giving up to get it?” in which he focussed on the evidence in the UK on the opportunity cost of NICE decisions, looking at the Claxton et al. work, the Barnsley et al critique, and work by Karlsberg Schaffer et al. on Wales and on Scotland.
Options for Formulary Development in Middle-Income Countries by Karla Hernandez-Villafuerte A number of middle-income countries (MICs) are evolving their health systems toward universal health coverage for patient populations. Such countries often have limited drug formularies and some form of essential drugs list. This presentation explores options for bridging the organisation of the health system and its priorities, and provides a framework for developing drug formularies.
Collaboration between Sub-Saharan African researchers is important in the generation and transfer of evidence to support the decision making process for health priority setting. This presentation provides an evaluation of collaboration patterns between countries.
Structured decision making approaches to the inclusion of multiple criteria in HTA by Nancy Devlin Multiple criteria are already used in HTA – so the question isn’t whether to employ multiple criteria, but how this is best done. OHE’s Professor Devlin presented on “structured decision making approaches to the inclusion of multiple criteria in HTA.”
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!